Neuberger Berman Group
MDCO

Neuberger Berman Group’s Medicines Co MDCO Stock Holding History

Neuberger Berman Group’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,000
Closed -$425K – 1671
2019
Q4 		$425K Buy
+5,000
New +$333K ﹤0.01% 1317
2017
Q3 		– Sell
-18,000
Closed -$684K – 1666
2017
Q2 		$684K Buy
18,000
+9,000
+100% +$401K ﹤0.01% 1244
2017
Q1 		$440K Sell
9,000
-22,500
-71% -$1.03M ﹤0.01% 1334
2016
Q4 		$1.07M Buy
+31,500
New +$1.12M ﹤0.01% 1123
2014
Q2 		– Sell
-8,390
Closed -$238K – 1776
2014
Q1 		$238K Sell
8,390
-453,510
-98% -$15M ﹤0.01% 1496
2013
Q4 		$17.8M Buy
461,900
+452,990
+5,084% +$16.2M 0.02% 674
2013
Q3 		$299K Sell
8,910
-60,680
-87% -$1.93M ﹤0.01% 1403
2013
Q2 		$2.14M Buy
+69,590
New +$2.33M ﹤0.01% 1041

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Neuberger Berman Group's MDCO Position: Q1 2020 in Review

Neuberger Berman Group sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 5,000 shares — an estimated $425K sold.

Neuberger Berman Group first reported a position in MDCO in Q2 2013 and held it in 8 quarters. The position peaked at $17.8M in Q4 2013. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Neuberger Berman Group reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Neuberger Berman Group sold 5,000 Medicines Co shares in Q1 2020, an estimated $425K.
  • Neuberger Berman Group first reported a position in Medicines Co in Q2 2013 and held it in 8 quarters.
  • Neuberger Berman Group's Medicines Co position peaked at $17.8M in Q4 2013.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Neuberger Berman Group's 13F filing for Q1 2020, filed 14 May 2020.